APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16 | -57.9% | 419 | 0.0% | 0.00% | – |
Q2 2023 | $38 | +31.0% | 419 | -5.8% | 0.00% | – |
Q1 2023 | $29 | +26.1% | 445 | 0.0% | 0.00% | – |
Q4 2022 | $23 | -99.9% | 445 | +12.1% | 0.00% | – |
Q3 2022 | $27,000 | +50.0% | 397 | 0.0% | 0.00% | – |
Q2 2022 | $18,000 | +20.0% | 397 | +33.2% | 0.00% | – |
Q1 2022 | $15,000 | +7.1% | 298 | 0.0% | 0.00% | – |
Q4 2021 | $14,000 | +40.0% | 298 | 0.0% | 0.00% | – |
Q3 2021 | $10,000 | 0.0% | 298 | +87.4% | 0.00% | – |
Q2 2021 | $10,000 | +42.9% | 159 | 0.0% | 0.00% | – |
Q1 2021 | $7,000 | -12.5% | 159 | +12.0% | 0.00% | – |
Q4 2020 | $8,000 | -38.5% | 142 | -66.1% | 0.00% | – |
Q3 2020 | $13,000 | +18.2% | 419 | 0.0% | 0.00% | – |
Q2 2020 | $11,000 | 0.0% | 419 | 0.0% | 0.00% | – |
Q1 2020 | $11,000 | 0.0% | 419 | +16.1% | 0.00% | – |
Q4 2019 | $11,000 | +10.0% | 361 | -9.3% | 0.00% | – |
Q3 2019 | $10,000 | 0.0% | 398 | 0.0% | 0.00% | – |
Q2 2019 | $10,000 | +42.9% | 398 | +11.2% | 0.00% | – |
Q1 2019 | $7,000 | 0.0% | 358 | -28.4% | 0.00% | – |
Q4 2018 | $7,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |